Viewing Study NCT03644069

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-02-25 @ 4:58 PM
Study NCT ID: NCT03644069
Status: UNKNOWN
Last Update Posted: 2019-03-19
First Post: 2018-05-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
Sponsor: ImmusanT, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Celiac Disease View
None Celiac View
None Intestinal Disease View
None Malabsorption Syndromes View
None Gastrointestinal Disease View
None Digestive System Disease View
None Gluten Sensitivity View
None Autoimmune Diseases View
Keywords: